Profile data is unavailable for this security.
About the company
Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. It operates through Hybrigenics Corporation and Imaxio.
- Revenue in EUR (TTM)0.00
- Net income in EUR-69.16k
- Incorporated1998
- Employees17.00
- LocationHybrigenics SA3-5 impasse ReillePARIS 75014FranceFRA
- Phone+33 158103800
- Fax+33 158103849
- Websitehttps://www.hybrigenics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rapid Nutrition PLC | 1.82m | -1.45m | 977.25k | 9.00 | 41.79 | 577.75 | -- | 0.5379 | 0.0017 | 0.0017 | 0.0034 | 0.0001 | 1.84 | 3.90 | 3.05 | 201,885.20 | -146.98 | -- | -1,011.07 | -- | 71.47 | -- | -79.74 | -- | 1.07 | -- | 0.7674 | -- | -1.50 | -- | -1,090.33 | -- | -- | -- |
| Theravet SA | -100.00bn | -100.00bn | 1.86m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Biophytis SA | 0.00 | -17.03m | 3.09m | 26.00 | -- | -- | -- | -- | -6.55 | -6.55 | 0.00 | -1.48 | 0.00 | -- | -- | -- | -100.31 | -97.52 | -1,481.81 | -487.25 | -- | -- | -- | -- | -- | -12.25 | -- | -- | -- | -- | 29.69 | -- | 14.25 | -- |
| Hybrigenics SA | 0.00 | -69.16k | 3.84m | 17.00 | -- | 0.2742 | -- | -- | -0.0003 | -0.0003 | 0.00 | 0.0361 | 0.00 | -- | -- | -- | -0.7067 | -35.48 | -0.877 | -48.94 | -- | -- | -- | -5,115.72 | -- | -- | 0.1032 | -- | 100.00 | -- | 78.83 | -- | -- | -- |
| Medesis Pharma SA | 0.00 | -2.79m | 4.06m | 10.00 | -- | -- | -- | -- | -0.6324 | -0.6324 | 0.00 | -0.5862 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.14 | -23.17 | -- | -- | -100.00 | -- | -3.87 | -- | -- | -- |
| IntegraGen SA | 12.49m | -123.83k | 4.37m | 57.00 | -- | 2.25 | 53.67 | 0.3501 | -0.0179 | -0.0179 | 1.88 | 0.2887 | 1.24 | 9.09 | 3.09 | 198,274.60 | -1.23 | -4.20 | -4.00 | -9.43 | 64.75 | 64.10 | -0.9913 | -3.67 | 1.23 | -- | 0.418 | -- | 16.27 | 16.08 | -122.78 | -- | -- | -- |
| Theranexus SA | 0.00 | -6.83m | 8.22m | 19.00 | -- | 3.70 | -- | -- | -1.09 | -1.09 | 0.00 | 0.2863 | 0.00 | -- | -- | 0.00 | -70.79 | -42.66 | -82.29 | -47.97 | -- | -- | -- | -- | -- | -1,058.68 | 0.6212 | -- | -- | -- | -3.97 | -- | -33.23 | -- |
| Quantum Genomics SA | 10.06k | -3.17m | 9.20m | 3.00 | -- | 10.54 | -- | 914.68 | -0.091 | -0.091 | 0.0003 | 0.0125 | 0.0007 | -- | 0.0016 | 3,353.33 | -23.14 | -60.77 | -95.19 | -102.24 | -14,205.07 | -3,548.91 | -31,520.38 | -3,374.13 | -- | -146.53 | 0.8615 | -- | -98.34 | -- | 87.28 | -- | -- | -- |
| Ikonisys SA | 538.56k | -2.40m | 15.05m | 11.00 | -- | 0.8235 | -- | 27.94 | -0.2499 | -0.2499 | 0.056 | 1.75 | 0.0246 | 1.14 | 6.20 | 48,960.00 | -10.94 | -- | -12.55 | -- | 2.72 | -- | -444.76 | -- | 0.0818 | -36.79 | 0.1007 | -- | 68.94 | -- | -328.57 | -- | -- | -- |
| Acticor Biotech SA | 0.00 | -18.65m | 15.47m | 24.00 | -- | 32.93 | -- | -- | -1.68 | -1.68 | 0.00 | 0.0298 | 0.00 | -- | -- | 0.00 | -145.59 | -- | -297.22 | -- | -- | -- | -- | -- | -- | -9.32 | 0.9504 | -- | -- | -- | -25.94 | -- | -- | -- |
| Valerio Therapeutics SA | 1.80m | -20.34m | 16.70m | 19.00 | -- | 1.12 | -- | 9.28 | -0.1566 | -0.1566 | 0.0133 | 0.0961 | 0.0459 | -- | 1.07 | 94,736.84 | -51.92 | -34.19 | -67.72 | -40.59 | 70.39 | 84.11 | -1,130.22 | -586.99 | -- | -171.66 | 0.3776 | -- | 24.74 | -21.73 | -4.00 | -- | 32.39 | -- |
| Plant Advanced Technologies PAT SA | 2.34m | -849.00k | 16.76m | 56.00 | -- | 2.27 | -- | 7.16 | -0.7853 | -0.7853 | 2.15 | 6.70 | 0.1368 | 0.9869 | 2.87 | 41,767.86 | -4.91 | -3.18 | -7.20 | -4.04 | 22.83 | 98.91 | -35.87 | -27.90 | 0.8691 | -16.73 | 0.4472 | -- | 1.48 | 23.72 | 25.13 | -- | 3.57 | -- |
